Companies
- Companies
- Browse
Companies
Sankyo Co. Ltd. is currently the second largest pharmaceutical company in Japan. It is famous as the founder of HMG-CoA reductase inhibitor anti-hyperlipidemia drugs. More
The company has evolved into producer of pharmaceuticals, agrochemicals, advanced materials, household products, processed plastic products, and related machines and systems More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2009 - 20 pages - $995
Nov 2010 - 40 pages - $500
Nov 2011 - 4 pages - $3,490
Dec 2010 - 19 pages - $99
Nov 2011 - 43 pages - $3,800
Dec 2009 - 121 pages - $7,600
Dec 2010 - 129 pages - $7,600
Sep 2011 - 62 pages - $5,700
May 2010 - 9 pages - $75
Japan Interventional Radiology in Oncology Study Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 25 pages - $500
Your selection
Browse By
- Therapeutic target
- Anti-oxidant
- Bladder cancer
- Bone cancer
- Brain cancer
- Breast cancer
- Cancer (other)
- Cancer side effects
- Cervical cancer
- Colorectal cancer
- Head and neck cancer
- Kaposi's sarcoma
- Kidney cancer
- Leukemia
- Liver cancer
- Lung cancer
- Lymphoma
- Ovarian cancer
- Pancreatic cancer
- Polyps
- Prostate cancer
- Skin cancer
- Stomach/Esophageal
- Testicular cancer
- Transplant
- Treatments
- Tumor (other)
- Vaginal Cancer
- Womb cancer
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us